INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 178 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $21 | -58.0% | 25,895 | -18.9% | 0.00% | – |
Q4 2022 | $50 | -99.9% | 31,932 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $55,000 | +17.0% | 31,932 | +17.5% | 0.00% | – |
Q2 2022 | $47,000 | -47.2% | 27,173 | +9.2% | 0.00% | -100.0% |
Q1 2022 | $89,000 | -66.8% | 24,893 | -53.6% | 0.00% | 0.0% |
Q4 2021 | $268,000 | +38.1% | 53,606 | +98.2% | 0.00% | -50.0% |
Q3 2021 | $194,000 | -27.9% | 27,048 | -6.9% | 0.00% | 0.0% |
Q2 2021 | $269,000 | +11.2% | 29,040 | +11.2% | 0.00% | -77.8% |
Q1 2021 | $242,000 | +10.5% | 26,119 | +5.5% | 0.01% | +12.5% |
Q4 2020 | $219,000 | -22.6% | 24,762 | +1.6% | 0.01% | -33.3% |
Q3 2020 | $283,000 | -54.4% | 24,377 | +5.9% | 0.01% | -58.6% |
Q2 2020 | $620,000 | +404.1% | 23,021 | +39.1% | 0.03% | +866.7% |
Q1 2020 | $123,000 | +132.1% | 16,550 | +2.1% | 0.00% | +200.0% |
Q4 2019 | $53,000 | +60.6% | 16,205 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $33,000 | -31.2% | 16,205 | -0.8% | 0.00% | 0.0% |
Q2 2019 | $48,000 | 0.0% | 16,341 | +27.4% | 0.00% | 0.0% |
Q1 2019 | $48,000 | -4.0% | 12,824 | +3.6% | 0.00% | 0.0% |
Q4 2018 | $50,000 | +2.0% | 12,382 | -1.8% | 0.00% | 0.0% |
Q2 2018 | $49,000 | -5.8% | 12,606 | +15.1% | 0.00% | 0.0% |
Q1 2018 | $52,000 | +13.0% | 10,949 | -1.4% | 0.00% | 0.0% |
Q4 2017 | $46,000 | -30.3% | 11,110 | +6.7% | 0.00% | -50.0% |
Q3 2017 | $66,000 | – | 10,417 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|